Longhitano Elisa, Bellone Federica, Cernaro Valeria, Squadrito Giovanni, Santoro Domenico
Unit of Nephrology and Dialysis, Department of Clinical and Experimental Medicine, A.O.U. "G.Martino", University of Messina, 98125, Messina, Italy.
Unit of Interne Medicine, Department of Clinical and Experimental Medicine, A.O.U. "G.Martino", University of Messina, 98125, Messina, Italy.
J Nephrol. 2025 Mar;38(2):733-737. doi: 10.1007/s40620-024-02148-7. Epub 2024 Dec 14.
Idiopathic inflammatory myopathies represent a spectrum of autoimmune disorders primarily characterized by muscle inflammation. While renal involvement in idiopathic inflammatory myopathies has historically been considered rare, recent findings indicate a prevalence of approximately 21-23%. Renal manifestations in idiopathic inflammatory myopathies are generally secondary to acute renal injury from rhabdomyolysis or, more rarely, occur through autoimmune mechanisms leading to glomerulonephritis. Here, we present the case of a 21-year-old male diagnosed with idiopathic inflammatory myopathy positive for anti-Jo antibodies and concurrent C3 glomerulonephritis, which improved following Rituximab therapy. The description of this case provides insights for future research into the role of alternative complement pathway dysregulation in idiopathic inflammatory myopathy-associated C3 glomerulopathy.
特发性炎性肌病是一类主要以肌肉炎症为特征的自身免疫性疾病谱。虽然特发性炎性肌病的肾脏受累在历史上一直被认为很罕见,但最近的研究结果表明其患病率约为21%-23%。特发性炎性肌病的肾脏表现通常继发于横纹肌溶解引起的急性肾损伤,或者更罕见地,通过自身免疫机制导致肾小球肾炎。在此,我们报告一例21岁男性患者,诊断为抗Jo抗体阳性的特发性炎性肌病并并发C3肾小球肾炎,经利妥昔单抗治疗后病情改善。该病例描述为未来研究替代补体途径失调在特发性炎性肌病相关C3肾小球病中的作用提供了见解。